Old Web
English
Sign In
Acemap
>
authorDetail
>
Jacqueline Corrigan-Curay
Jacqueline Corrigan-Curay
Center for Drug Evaluation and Research
Medicine
Family medicine
Intensive care medicine
Immunology
drug approval
5
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
FDA Breakthrough Therapy Designation–Trial Design and More – Commentary
2021
Clinical Pharmacology & Therapeutics
Jacqueline Corrigan-Curay
Peter Stein
Show All
Source
Cite
Save
Citations (0)
Leveraging the Capabilities of the FDA's Sentinel System To Improve Kidney Care.
2020
Journal of The American Society of Nephrology
Sruthi Adimadhyam
Erin F. Barreto
Noelle M. Cocoros
Sengwee Toh
Jeffrey S. Brown
Judith C. Maro
Jacqueline Corrigan-Curay
Gerald J. Dal Pan
Robert Ball
David Martin
Michael Nguyen
Richard Platt
Xiaojuan Li
Show All
Source
Cite
Save
Citations (1)
Randomized, observational, interventional, and real-world-What's in a name?
2020
Pharmacoepidemiology and Drug Safety
John Concato
Peter Stein
Gerald J. Dal Pan
Robert Ball
Jacqueline Corrigan-Curay
Show All
Source
Cite
Save
Citations (2)
Clarifications regarding the authority and role of FDA in drug approval
2019
American Journal of Transplantation
M. Cavaille-Coll
Peter P. Stein
Jacqueline Corrigan-Curay
Show All
Source
Cite
Save
Citations (0)
1